Related Experiment Video
Updated: May 31, 2025
07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.1K
Nanoparticles in gynecologic cancers: a bibliometric and visualization analysis.
Yunzhe Zhou1, Lizhang Chen1, Tingting Wang1
1Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
Frontiers in Oncology
|January 23, 2025
Summary
Nanoparticles show significant advancements in treating gynecologic cancers, focusing on drug delivery and broader applications. Future research will explore silver and gold nanoparticles for enhanced cancer therapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Gynecological cancers are a major threat to women's health, affecting lifespan, quality of life, and fertility.
- Nanoparticles offer unique properties like small size and high permeability, making them promising for targeted cancer therapy.
- This review examines recent progress in nanoparticle applications for gynecologic cancers.
Purpose of the Study:
- To review and analyze the recent advancements in nanoparticle applications for gynecologic cancers.
- To identify key research trends, leading contributors, and influential publications in the field.
- To provide insights for future research directions in nanoparticle-based gynecologic cancer treatment.
Main Methods:
- A comprehensive literature search was conducted on the Web of Science Core Collection (WOSCC) from 2004 to 2024.
- Bibliometric analysis and data visualization were performed using R software, VOSviewer, and CiteSpace.
- A total of 2,843 publications were analyzed to identify research trends and key players.
Main Results:
- Publication output has significantly increased over the last two decades.
- China and the Chinese Academy of Sciences are leading in productivity, with Sood, A K and Siegel, Rl as prominent authors.
- Key research areas include nanoparticle drug delivery and broader applications, with future focus on silver nanoparticles, gold nanoparticles, and green synthesis.
Conclusions:
- Nanoparticle research in gynecologic cancers has rapidly advanced over the past 20 years.
- Current research emphasizes drug delivery and applications, with a growing interest in silver and gold nanoparticles.
- Future efforts should focus on optimizing synthesis and progressing from preclinical to clinical applications.
